Articles & posts – MFN

This page contains articles and posts from 2025.

Neola Medical's expansion in the U.S. market is gaining momentum, with significant progress in launch preparations. As part of the company’s strategy...
Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently...
"This is a step towards optimizing the conditions for a successful clinical study on preterm born infants in the U.S.", says CEO anna Sjöström After...
The company's product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström...
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company's medical device received CB certification...
Did you miss all the exciting updates when CEO Hanna Sjöström and CFO Christian Gyllenberg presented Neola Medical’s Q2-report of 2024 at Finwire TV?...
Discover how the breakthrough patented technology in Neola®, biomedical GASMAS, a unique method grounded in laser spectroscopy for observing the lung...
Hanna Sjöström's career trajectory is impressive: first an international top career at Coca-Cola and L’Oréal, now CEO of a life-saving startup. Chefakademin's...
With the aim of taking Neola Medical’s cutting-edge lung monitoring for preterm born infants to larger patients such as children and adults, a Master...
Press communication Lund, Sweden, June 4, 2024 This is a translation of the Swedish press release published 2024-06-04 Neola Medical AB (publ) announced...

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in Neola Medical